What medications can lower high uric acid levels?

Under normal circumstances, medications such as allopurinol, febuxostat, benzbromarone, probenecid, and sodium bicarbonate may be used to lower elevated serum uric acid levels. A detailed analysis follows:

1. Allopurinol: An xanthine oxidase inhibitor that reduces serum uric acid levels by inhibiting uric acid production. It is indicated for patients with hyperuricemia due to overproduction of uric acid. Potential adverse effects include rash and hepatic dysfunction; close monitoring is therefore essential during treatment. During the initial phase of therapy, allopurinol may trigger acute gout attacks; concurrent use of colchicine is recommended for prophylaxis.

2. Febuxostat: Also an xanthine oxidase inhibitor, febuxostat demonstrates potent uric acid–lowering efficacy and has relatively minimal renal impact, making it suitable for patients with mild-to-moderate renal impairment. However, potential side effects include abnormal liver function tests and rash; thus, periodic monitoring of hepatic function is required during treatment.

3. Benzbromarone: A uricosuric agent that lowers serum uric acid by inhibiting renal tubular reabsorption of uric acid, thereby enhancing its urinary excretion. It is appropriate for patients with normal or mildly impaired renal function. Adequate hydration is crucial during treatment to prevent urinary uric acid crystallization; concomitant urine alkalization may further improve uric acid solubility. Adverse effects may include gastrointestinal discomfort and rash.

4. Probenecid: Another uricosuric agent with a mechanism of action similar to benzbromarone. It competitively inhibits renal tubular reabsorption of uric acid, increasing its urinary excretion. However, due to its relatively high incidence of adverse effects—including gastrointestinal disturbances and hypersensitivity reactions—as well as numerous drug–drug interactions, its clinical use is currently limited.

5. Sodium bicarbonate: An alkalizing agent that indirectly lowers serum uric acid by increasing urinary pH, thereby enhancing uric acid solubility and promoting its excretion. It is commonly used as an adjunctive therapy in combination with other uric acid–lowering agents. Urinary pH should be monitored regularly during treatment to avoid excessive alkalization.

The selection of uric acid–lowering medication should be individualized based on the underlying cause of hyperuricemia, hepatic and renal function status, history of gout attacks, and other relevant clinical factors—and must always be guided by a qualified physician. Patients should closely monitor for potential adverse drug reactions during treatment and seek prompt medical attention if any adverse symptoms occur.